{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:11:57Z","timestamp":1793815917862,"version":"4.6.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015731","name":"Bayer Yakuhin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bbrc.2026.153332","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:40:16Z","timestamp":1768981216000},"page":"153332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Nonsteroidal mineralocorticoid receptor antagonist finerenone ameliorates cardiac hypertrophy with increasing glucocorticoid signaling sensitivity"],"prefix":"10.1016","volume":"802","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5368-8485","authenticated-orcid":false,"given":"Kei","family":"Morikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9840-3347","authenticated-orcid":false,"given":"Yuichiro","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8232-8185","authenticated-orcid":false,"given":"Takumi","family":"Nagakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Fujiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9627-9373","authenticated-orcid":false,"given":"Shinsuke","family":"Hanatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Matsuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Izumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4314-259X","authenticated-orcid":false,"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153332_bib1","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.cmet.2024.06.003","article-title":"Human cardiac metabolism","volume":"36","author":"Bornstein","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbrc.2026.153332_bib2","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction JACC scientific statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2026.153332_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41581-024-00812-6","article-title":"A united vision for cardiovascular\u2013kidney\u2013metabolic health","volume":"20","author":"Quaggin","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbrc.2026.153332_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1120085","article-title":"Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction","volume":"9","author":"Yang","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbrc.2026.153332_bib5","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153332_bib6","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153332_bib7","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Investigators, finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153332_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S2213-8587(24)00309-7","article-title":"Investigators, Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial","volume":"13","author":"Butt","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bbrc.2026.153332_bib9","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2026.153332_bib10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.153332_bib11","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153332_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153332_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41467-018-02866-0","article-title":"Single-cell full-length total RNA sequencing uncovers dynamics of recursive splicing and enhancer RNAs","volume":"9","author":"Hayashi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153332_bib14","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s12325-024-02780-6","article-title":"Efficacy and safety of esaxerenone in hypertensive patients with left ventricular hypertrophy (ESES-LVH) Study: a multicenter, Open-Label, prospective, interventional Study","volume":"41","author":"Yamamoto","year":"2024","journal-title":"Adv. Ther."},{"key":"10.1016\/j.bbrc.2026.153332_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tem.2015.10.001","article-title":"Cardiac GR and MR: from development to pathology","volume":"27","author":"Richardson","year":"2016","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2026.153332_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.med.48.1.231","article-title":"Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance","volume":"48","author":"Funder","year":"1997","journal-title":"Medicine"},{"key":"10.1016\/j.bbrc.2026.153332_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrm.2016.152","article-title":"Glucocorticoid receptor control of transcription: precision and plasticity via allostery","volume":"18","author":"Weikum","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.153332_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tibs.2024.01.012","article-title":"Glucocorticoid receptor signaling: intricacies and therapeutic opportunities","volume":"49","author":"Clarisse","year":"2024","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbrc.2026.153332_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aau9685","article-title":"Cardiomyocyte glucocorticoid and mineralocorticoid receptors directly and antagonistically regulate heart disease in mice","volume":"12","author":"Oakley","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbrc.2026.153332_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.yjmcc.2019.03.019","article-title":"Pressure overload inhibits glucocorticoid receptor transcriptional activity in cardiomyocytes and promotes pathological cardiac hypertrophy","volume":"130","author":"Matsuhashi","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2026.153332_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00018-023-04900-x","article-title":"Crosstalk between glucocorticoid and mineralocorticoid receptors boosts glucocorticoid-induced killing of multiple myeloma cells","volume":"80","author":"Clarisse","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2026.153332_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2413737121","article-title":"The glucocorticoid receptor potentiates aldosterone-induced transcription by the mineralocorticoid receptor","volume":"121","author":"Johnson","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.153332_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108488","article-title":"Molecular interactions of glucocorticoid and mineralocorticoid receptors define novel transcription and biological functions","volume":"301","author":"Sueyoshi","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.153332_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jc.2002-020354","article-title":"Glucocorticoid-induced increase in lymphocytic FKBP51 Messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability","volume":"88","author":"Vermeer","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2026.153332_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1379\/CSC-32R.1","article-title":"Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids","volume":"9","author":"Hubler","year":"2004","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.bbrc.2026.153332_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109185","article-title":"Mineralocorticoid receptors dampen glucocorticoid receptor sensitivity to stress via regulation of FKBP5","volume":"35","author":"Hartmann","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2026.153332_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042166","article-title":"FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop","volume":"7","author":"L\u00fctzner","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153332_bib28","doi-asserted-by":"crossref","first-page":"E572","DOI":"10.1152\/ajpendo.00214.2015","article-title":"Transcriptional regulation of FoxO3 gene by glucocorticoids in murine myotubes","volume":"310","author":"Kuo","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2026.153332_bib29","doi-asserted-by":"crossref","first-page":"20814","DOI":"10.1074\/jbc.M500528200","article-title":"The FOXO3a transcription factor regulates Cardiac Myocyte Size downstream of AKT signaling","volume":"280","author":"Skurk","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.153332_bib30","first-page":"2758","article-title":"Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice","volume":"119","author":"Sundaresan","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.153332_bib31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.121.055727","article-title":"DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics","volume":"145","author":"Zhuang","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2026.153332_bib32","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.123.324103","article-title":"Blunted Cardiac mitophagy in response to Metabolic stress contributes to HFpEF","volume":"135","author":"Yoshii","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2026.153332_bib33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/CIRCRESAHA.123.322654","article-title":"Mitochondrial GSNOR alleviates cardiac dysfunction via ANT1 denitrosylation","volume":"133","author":"Tang","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2026.153332_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trsl.2021.08.003","article-title":"Aldosterone suppresses cardiac mitochondria","volume":"239","author":"Hung","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.bbrc.2026.153332_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00395-019-0758-6","article-title":"Glucocorticoids preserve the t-tubular system in ventricular cardiomyocytes by upregulation of autophagic flux","volume":"114","author":"Seidel","year":"2019","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bbrc.2026.153332_bib36","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4161\/cc.29272","article-title":"Dexamethasone-induced autophagy mediates muscle atrophy through mitochondrial clearance","volume":"13","author":"Troncoso","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2026.153332_bib37","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.153332_bib38","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann. Intern. Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26000963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26000963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:18:01Z","timestamp":1770229081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26000963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":38,"alternative-id":["S0006291X26000963"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153332","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonsteroidal mineralocorticoid receptor antagonist finerenone ameliorates cardiac hypertrophy with increasing glucocorticoid signaling sensitivity","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153332"}}